ARTICLE
Use of Vitamins K antagonists in non-valvular atrial fibrillation thromboembolic risk prevention in Burkina Faso
- The Pan African medical journal , 24 : 108-108
Lien de l'article :
https://doi.org/10.11604/pamj.2016.24.108.7100
Discipline :
Médecine fondamentale
Auteur(s) :
Rélwendé Aristide Yaméogo, Jonas Koudougou Kologo, Germain Mandi, Hervé Poko Kabore, Georges Rosario Christian Millogo, Arthur André Taryetba, A.K. Samadoulougou, Patrice Zabsonré
Auteur(s) tagués :
YAMEOGO Relwende Aristide
Renseignée par : YAMEOGO Relwende Aristide
Résumé
Guidelines on thromboembolic risk prevention are poorly used in the cardiology department. But the use of scoring systems allows the assessment of vitamins K antagonists treatment benefit/risk in atrial fibrillation, and minimizes the hemorrhagic risk.
Mots-clés
Medicine, Atrial fibrillation, Cardiology, Internal medicine, Anticoagulant